Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Effect of Calcium β-hydroxy-β-methylbutyrate Supplementation in Sarcopenia in Liver Cirrhosis:A Randomized Double-blind Controlled Trial
Authors not listed
Shanghai Zhongshan Hospital · 2018
Abstract
This study is to evaluate the effect of CaHMB in the treatment of sarcopenia in liver cirrhosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Anonymous. (2018). The Effect of Calcium β-hydroxy-β-methylbutyrate Supplementation in Sarcopenia in Liver Cirrhosis:A Randomized Double-blind Controlled Trial. <em>Shanghai Zhongshan Hospital</em>. https://clinicaltrials.gov/study/NCT03605147
Vancouver
Anonymous. The Effect of Calcium β-hydroxy-β-methylbutyrate Supplementation in Sarcopenia in Liver Cirrhosis:A Randomized Double-blind Controlled Trial. Shanghai Zhongshan Hospital. 2018.
BibTeX
@misc{anon2018TheEff,
title = {The Effect of Calcium β-hydroxy-β-methylbutyrate Supplementation in Sarcopenia in Liver Cirrhosis:A Randomized Double-blind Controlled Trial},
author = {Anonymous},
journal = {Shanghai Zhongshan Hospital},
year = {2018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Kangbuk Samsung Hospital 2022
Open access · US-GOV
Impact of Acute Kidney Injury on Sarcopenia and Frailty in Patients With Liver Cirrhosis
ENCell 2027
Open access · US-GOV
A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 1/2 Clinical Trial to Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia
Lipocine Inc. 2021
Open access · US-GOV
A Phase 2, Randomized Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia
University of Roma La Sapienza 2019
Open access · US-GOV
Beta-Hydroxy-Beta-Methylbutyrate Supplementation and Physical Activity in Liver Cirrhosis: a Controlled Trial
Hepatology 2021
Preprint · OA
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
The Affiliated Hospital of Qingdao University 2021
Open access · US-GOV